Exact Mass: 321.0590226

Exact Mass Matches: 321.0590226

Found 255 metabolites which its exact mass value is equals to given mass value 321.0590226, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

S-Methyl GSH

2-Amino-5-((1-((carboxymethyl)amino)-3-(methylthio)-1-oxopropan-2-yl)amino)-5-oxopentanoic acid

C11H19N3O6S (321.0994514)

S-Methylglutathione is an S-substitued?glutathione and a stronger nucleophile than GSH[1]. S-Methylglutathione has inhibitory effect on glyoxalase 1[2].

Deoxy-5-methylcytidylate

2-Deoxy-5-methylcytidine-5-monophosphate disodium salt

C10H16N3O7P (321.0725836)

L-L-Homoglutathione

2-amino-4-[(Z)-{1-[(Z)-(2-carboxyethyl)-C-hydroxycarbonimidoyl]-2-sulfanylethyl}-C-hydroxycarbonimidoyl]butanoic acid

C11H19N3O6S (321.0994514)

L-l-homoglutathione is a member of the class of compounds known as hybrid peptides. Hybrid peptides are compounds containing at least two different types of amino acids (alpha, beta, gamma, delta) linked to each other through a peptide bond. L-l-homoglutathione is practically insoluble (in water) and a moderately acidic compound (based on its pKa). L-l-homoglutathione can be found in pulses, which makes L-l-homoglutathione a potential biomarker for the consumption of this food product. L-L-Homoglutathione is found in pulses. L-L-Homoglutathione occurs in seeds of various legume

2-Amino-4-oxo-4-alpha-hydroxy-6-(erythro-1',2',3'-trihydroxypropyl)-5,6,7,8-tetrahydroxypterin

2-Amino-4-oxo-3,4,5,6,7,8-hexahydro-6-(erythro-1,2,3-trihydroxypropyl)-5,6,7,8-tetrahydroxypteridine

C9H15N5O8 (321.092059)

2-Amino-4-oxo-4-alpha-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)-5,6,7,8-tetrahydroxypterin is a pterin derivative. Pterin is a heterocyclic compound composed of a pyrazine ring and a pyrimidine ring with Several tautomers; the pyrimidine ring has a carbonyl oxygen and an amino group. As a group, pterins are compounds that are derivatives of 2-amino-4-oxopteridine, with additional functional groups attached to the pyrazine ring. Pterins were first discovered in the pigments of butterfly wings and perform many roles in coloration in the biological world. Pterins also function as cofactors in enzyme catalysis (Wikipedia). Some pterin derivatives (biopterin, 6-formylpterin, 6-carboxypterin) accumulate in the skin of patients affected by vitiligo, a depigmentation disorder, where the protection against UV radiation fails due to the lack of melanin. Pterins participate in biologically important photosensitization processes; for example, pterins act as sensitizers in photochemical reactions that induce DNA damage4,5 and are able to generate singlet molecular oxygen6 and other reactive oxygen species (PMID: 19199487). 2-Amino-4-oxo-4-alpha-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)-5,6,7,8-tetrahydroxypterin is a pterin derivative. Pterin is a heterocyclic compound composed of a pyrazine ring and a pyrimidine ring with Several tautomers; the pyrimidine ring has a carbonyl oxygen and an amino group. As a group, pterins are compounds that are derivatives of 2-amino-4-oxopteridine, with additional functional groups attached to the pyrazine ring. Pterins were first discovered in the pigments of butterfly wings and perform many roles in coloration in the biological world. Pterins also function as cofactors in enzyme catalysis .

Flamprop-M

C16H13ClFNO3 (321.0567950000001)

Beta-Citryl-L-glutamic acid

2-{[3-carboxy-2-(carboxymethyl)-1,2-dihydroxypropylidene]amino}pentanedioate

C11H15NO10 (321.069593)

beta-Citryl-L-glutamic acid (beta-CG) is a derivative of glutamic acid. beta-CG which is known to occur in the brain, have been isolated from human urine. [HMDB] beta-Citryl-L-glutamic acid (beta-CG) is a derivative of glutamic acid. beta-CG which is known to occur in the brain, have been isolated from human urine.

7-Demethylmitomycin B; 6-Demethylmitomycin B

[(4S,6S,7R,8R)-7,13-dihydroxy-12-methyl-10,11-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),12-dien-8-yl]methyl carbamate

C14H15N3O6 (321.096081)

Clopidogrel

methyl (2S)-2-(2-chlorophenyl)-2-{4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}acetate

C16H16ClNO2S (321.0590226)

Clopidogrel is a potent oral antiplatelet agent often used in the treatment of coronary artery disease, peripheral vascular disease, and cerebrovascular disease. It is marketed by Bristol-Myers Squibb and Sanofi-Aventis under the trade name Plavix. -- Wikipedia; Clopidogrel is a potent oral antiplatelet agent often used in the treatment of coronary artery disease, peripheral vascular disease, and cerebrovascular disease. It is marketed by Bristol-Myers Squibb and Sanofi-Aventis under the trade name Plavix. It is also marketed in the generic form by Apotex, a large Canadian generic pharmaceutical company, though an injunction to withhold further shipments of their form is in effect while patent issues are dealt with. In 2005 it was the worlds second highest selling pharmaceutical with sales of US$5.9 billion. [HMDB] Clopidogrel is a potent oral antiplatelet agent often used in the treatment of coronary artery disease, peripheral vascular disease, and cerebrovascular disease. It is marketed by Bristol-Myers Squibb and Sanofi-Aventis under the trade name Plavix. -- Wikipedia; Clopidogrel is a potent oral antiplatelet agent often used in the treatment of coronary artery disease, peripheral vascular disease, and cerebrovascular disease. It is marketed by Bristol-Myers Squibb and Sanofi-Aventis under the trade name Plavix. It is also marketed in the generic form by Apotex, a large Canadian generic pharmaceutical company, though an injunction to withhold further shipments of their form is in effect while patent issues are dealt with. In 2005 it was the worlds second highest selling pharmaceutical with sales of US$5.9 billion. B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AC - Platelet aggregation inhibitors excl. heparin C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent > C190801 - P2Y12 Inhibitor D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Clopidogrel is an orally active platelet inhibitor that targets P2Y12 receptor. Clopidogrel is used to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease.

Cepharadione B

15,16-dimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,8,13,15-heptaene-11,12-dione

C19H15NO4 (321.10010300000005)

Cepharadione B is found in herbs and spices. Cepharadione B is an alkaloid from the woody roots of Piper auritum (Veracruz pepper

S-Glutaryldihydrolipoamide

5-[(7-carbamoyl-3-sulfanylheptyl)sulfanyl]-5-oxopentanoic acid

C13H23NO4S2 (321.1068438)

S-Glutaryldihydrolipoamide is involved in the lysine degradation pathway. S-Glutaryldihydrolipoamide can be irreversibly created from 2-Oxoadipate by 2-oxoglutarate dehydrogenase E1 component [EC:1.2.4.2]. S-Glutaryldihydrolipoamide can be reversibly created from Glutaryl-CoA by 2-oxoglutarate dehydrogenase E2 component (dihydrolipoamide. succinyltransferase) [EC:2.3.1.61]. S-Glutaryldihydrolipoamide is involved in the lysine degradation pathway. S-Glutaryldihydrolipoamide can be irreversibly created from 2-Oxoadipate by 2-oxoglutarate dehydrogenase E1 component [EC:1.2.4.2]. S-Glutaryldihydrolipoamide can be reversibly created from Glutaryl-CoA by 2-oxoglutarate dehydrogenase E2 component (dihydrolipoamide

Equol 4'-sulfate

(3S)-3-[4-(sulfooxy)phenyl]-3,4-dihydro-2H-1-benzopyran-7-olate

C15H13O6S (321.04328180000005)

4-Iodo-2,5-dimethoxyphenylisopropylamine

4-iodo-2,5-Dimethoxyphenylisopropylamine hydrochloride, (+-)-isomer

C11H16INO2 (321.0225746)

2-Amino-5-((1-((carboxymethyl)amino)-3-(methylthio)-1-oxopropan-2-yl)amino)-5-oxopentanoic acid

2-Amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-(methylsulphanyl)ethyl}-C-hydroxycarbonimidoyl)butanoic acid

C11H19N3O6S (321.0994514)

4-Chloro-8-methyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9A-triaza-benzo[CD]azulene-1-thione

6-chloro-11-methyl-10-(3-methylbut-2-en-1-yl)-1,3,10-triazatricyclo[6.4.1.0^{4,13}]trideca-4(13),5,7-triene-2-thione

C16H20ClN3S (321.10663900000003)

Clopidogrelum

Methyl 2-(2-chlorophenyl)-2-{4h,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}acetic acid

C16H16ClNO2S (321.0590226)

Calcein Blue

2-[(carboxymethyl)[(7-hydroxy-4-methyl-2-oxo-2H-chromen-8-yl)methyl]amino]acetic acid

C15H15NO7 (321.08484799999997)

Diclofensine

4-(3,4-dichlorophenyl)-7-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline

C17H17Cl2NO (321.06871320000005)

C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

1-(2,5-Dimethoxy-4-iodophenyl)-1-methylethylamine

C11H16INO2 (321.0225746)

Glycine, L-g-glutamyl-L-cysteinyl-, 3-methyl ester

2-Amino-4-({1-[(2-methoxy-2-oxoethyl)-C-hydroxycarbonimidoyl]-2-sulphanylethyl}-C-hydroxycarbonimidoyl)butanoic acid

C11H19N3O6S (321.0994514)

Menisporphine

5,10,11-trimethoxy-16-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1(16),2(7),3,5,9(17),10,12,14-octaen-8-one

C11H19N3O6S (321.0994514)

S-Methylglutathione is an S-substitued?glutathione and a stronger nucleophile than GSH[1]. S-Methylglutathione has inhibitory effect on glyoxalase 1[2].

dimethenamide ESA

C12H19NO5S2 (321.0704604)

An organosulfonic acid that is 2-oxoethanesulfonic acid substituted by a (2,4-dimethylthiophen-3-yl)(1-methoxypropan-2-yl)amino group at position 2. CONFIDENCE standard compound; EAWAG_UCHEM_ID 260 CONFIDENCE standard compound; INTERNAL_ID 2041

Maybridge1_001952

C15H15NO7 (321.08484799999997)

Diclofensine

C17H17Cl2NO (321.06871320000005)

C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

HMS2792C16

C13H15N5O3S (321.089556)

Maybridge4_003909

C15H10F3N3O2 (321.0725076)

ZINC105982

C16H19NO2S2 (321.08571539999997)

ZINC4364814

C16H19NO2S2 (321.08571539999997)

MMV652003

C15H11BF3NO3 (321.0784042)

GNF-Pf-4371

C16H16ClNO2S (321.0590226)

N-Fructosyl alliin - H2O

CHEMBL3331117

C19H15NO4 (321.10010300000005)

7-oxohernangerine

C18H11NO5 (321.0637196)

SCHEMBL17884294

C11H19N3O6S (321.0994514)

Ala Cys Glu

C11H19N3O6S (321.0994514)

Asp Met Gly

C11H19N3O6S (321.0994514)

Clopidogrel

Methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4h)-yl)acetate

C16H16ClNO2S (321.0590226)

B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AC - Platelet aggregation inhibitors excl. heparin C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent > C190801 - P2Y12 Inhibitor D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS INTERNAL_ID 2284; CONFIDENCE standard compound CONFIDENCE standard compound; INTERNAL_ID 2284 CONFIDENCE standard compound; INTERNAL_ID 8531 Clopidogrel is an orally active platelet inhibitor that targets P2Y12 receptor. Clopidogrel is used to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease.

MMV652003

C15H11NO3BF3 (321.0784042)

MMV007803

C16H16NO2ClS (321.05902260000005)

Dimethenamid-ESA

C12H19NO5S2 (321.0704604)

Cepharadione B

15,16-dimethoxy-10-methyl-10-azatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(16),2,4,6,8,13(17),14-heptaene-11,12-dione

C19H15NO4 (321.10010300000005)

(±)-Clopidogrel

C16H16ClNO2S (321.0590226)

4-(4-ETHOXY-PHENYLSULFAMOYL)-BENZOIC ACID

C15H15NO5S (321.06709)

2-amino-3-nitro-6-phenyl-4-thiophen-2-ylbenzonitrile

C17H11N3O2S (321.0571946)

6-Nitronaphtho[7,8,1,2,3-nopqr]tetraphene

C22H11NO2 (321.0789746)

4-[(4-Amino-5-methoxy-2-methylphenyl)azo]benzenesulfonic acid

C14H15N3O4S (321.078323)

1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine

2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine

C11H16INO2 (321.0225746)

D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D006213 - Hallucinogens

Methyl 2-(2-chlorophenyl)-2-(4,5-dihydrothieno[2,3-c]pyridin-6(7H)-yl)acetate

C16H16ClNO2S (321.0590226)

diethyl 5-chloro-8-methylquinoline-2,3-dicarboxylate

C16H16ClNO4 (321.0767806)

diethyl 6-chloro-8-methylquinoline-2,3-dicarboxylate

C16H16ClNO4 (321.0767806)

Methyl 3-(2,6-difluorophenylcarbamoyl)-4-Methoxybenzoate

C16H13F2NO4 (321.08126020000003)

N-(2-BroMophenyl)-9H-carbazole

C18H12BrN (321.0153052)

CHLORNIDINE)

C11H13Cl2N3O4 (321.02830780000005)

Cinnamyl-3,4-dihydroxy-α-cyanocinnamate

C19H15NO4 (321.10010300000005)

Cinnamyl-3,4-dihydroxy-α-cyanocinnamate (CDC) is a potent 12/15-Lipoxygenases (LO) inhibitor. Cinnamyl-3,4-dihydroxy-α-cyanocinnamate has the potential for the research of type 1 diabetes mellitus[1].

DIMETHYL 2-(2-NITRO-4-(TRIFLUOROMETHYL)PHENYL)MALONATE

C12H10F3NO6 (321.0460196)

[3-(1,3-benzoxazol-2-yl)-2-oxochromen-7-yl] acetate

C18H11NO5 (321.0637196)

tert-butyl 3-(5-bromopentoxy)azetidine-1-carboxylate

C13H24BrNO3 (321.09394540000005)

2-Bromo-1-(2-methylaminopropyl)adamantane hydrochloride

C14H25BrClN (321.08587800000004)

3-Bromo-1-(2-methylaminopropyl)adamantane hydrochloride

C14H25BrClN (321.08587800000004)

Fengabine

C17H17Cl2NO (321.06871320000005)

C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

Boc-L-3-Benzothienylalanine

C16H19NO4S (321.10347340000004)

(dimethyl)[10H-pyrido[3,2-b][1,4]benzothiazine-10-propyl]ammonium chloride

C16H20ClN3S (321.10663900000003)

2-((2-(TRIFLUOROMETHYL)BENZYL)OXY)ISOINDOLINE-1,3-DIONE

C16H10F3NO3 (321.06127460000005)

(-)-clopidogrel

C16H16ClNO2S (321.0590226)

(4-(N-(4-METHOXYBENZYL)SULFAMOYL)PHENYL)BORONIC ACID

C14H16BNO5S (321.08421960000004)

4-Imidazolidinone,5-(1H-indol-3-ylmethyl)-3-phenyl-2-thioxo-

C18H15N3OS (321.09357800000004)

8-HYDROXYQUINOLINE GLUCURONIDE

C15H15NO7 (321.08484799999997)

2-chloro-7-methyl-3-(5-phenyl-1,2,4-oxadiazol-3-yl)quinoline

C18H12ClN3O (321.0668852)

(E)-1-(3-(2-(7-CHLOROQUINOLIN-2-YL)VINYL)PHENYL)PROP-2-EN-1-OL

C20H16ClNO (321.09203560000003)

2-Bromo-9-phenyl-9H-carbazole

C18H12BrN (321.0153052)

Benzeneethanol,4-nitro-, 1-(4-methylbenzenesulfonate)

C15H15NO5S (321.06709)

Copper, bis[ethyl3-(oxo-kO)butanoato-kO]-

C12H18CuO6 (321.0399318)

(3-(N-(4-METHOXYBENZYL)SULFAMOYL)PHENYL)BORONIC ACID

C14H16BNO5S (321.08421960000004)

1-[ISOCYANO-(TOLUENE-4-SULFONYL)-METHYL]-NAPHTHALENE

C19H15NO2S (321.08234500000003)

[2,2:6,2-Terpyridine]-3,4-dicarboxylic acid

C17H11N3O4 (321.0749526)

Arsonic acid,[4-[(4-aminophenyl)azo]phenyl]- (9CI)

C12H12AsN3O3 (321.00945820000004)

Benzoic acid,5-[2-[4-(aminosulfonyl)phenyl]diazenyl]-2-hydroxy-

C13H11N3O5S (321.04193960000003)

2-chloro-8-methyl-3-(5-phenyl-1,2,4-oxadiazol-3-yl)quinoline

C18H12ClN3O (321.0668852)

ans-na

C16H12NNaO3S (321.0435562)

Phenyl[2-phenylthio)phenyl]carbamate

C19H15NO2S (321.08234500000003)

3-Bromo-N-phenylcarbazole

C18H12BrN (321.0153052)

Isocyano(2-naphthyl)methyl 4-methylphenyl sulfone

C19H15NO2S (321.08234500000003)

1H-Benzo[a]cyclopenta[f]quinolizinium,2,3,3a,5,6,11,12,12a-octahydro-8-hydroxy-, bromide (1:1)

C16H20BrNO (321.07281700000004)

(Z)-1-Phenyl-2-(phthalimidomethyl)cyclopropanecarboxylic acid

C19H15NO4 (321.10010300000005)

9-(4-Bromophenyl)carbazole

C18H12BrN (321.0153052)

Boc-D-3-Benzothienylalanine

C16H19NO4S (321.10347340000004)

BOC-3-(3-BENZOTHIENYL)-DL-ALANINE

C16H19NO4S (321.10347340000004)

1-Benzyl-3-(2,2,2-trifluoro-acetyl)piperidin-4-one HCl

C14H15ClF3NO2 (321.0743356)

3-(4-OXO-3,4-DIHYDROPYRIDO[3,2:4,5]FURO[3,2-D]PYRIMIDIN-2-YL)PHENYL ACETATE

C17H11N3O4 (321.0749526)

9-(3-Bromophenyl)-9H-carbazole

C18H12BrN (321.0153052)

2-(3-Bromo-2-oxopropyl)-3-methoxy-1-piperidinecarboxylic acid ethyl ester

C12H20BrNO4 (321.0575620000001)

4,5-DIMETHOXY-2-(2-THIOPHEN-2-YL-ACETYLAMINO)-BENZOIC ACID

C15H15NO5S (321.06709)

TETRAETHYLAMMONIUM (META)PERIODATE

C8H20INO4 (321.04370300000005)

Methyl 1-(5-bromopyridin-2-yl)-5-cyclopropyl-1H-pyrazole-4-carboxylate

C13H12BrN3O2 (321.0112832)

METHYL 5-AMINO-2-(4-NITRO-1-OXOISOINDOLIN-2-YL)-5-OXOPENTANOATE

C14H15N3O6 (321.096081)

ETHYL 8-ALLYL-5-HYDROXY-2-(METHYLTHIO)-7-OXO-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDINE-6-CARBOXYLATE

C14H15N3O4S (321.078323)

Isothipendyl hydrochloride

C16H20ClN3S (321.10663900000003)

D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist

1H-PYRROLO[2,3-B]PYRIDINE-1-SULFONAMIDE, N,N-DIMETHYL-3-(2,2,2-TRIFLUOROACETYL)-

C11H10F3N3O3S (321.0394946)

2-Bromo-3-cyclohexyl-1H-indole-6-carboxylic acid

C15H16BrNO2 (321.0364336)

4-[(4-METHYLPHENYL)SULFONYL]-3-NITROBENZOIC ACID

C14H11NO6S (321.03070660000003)

6,2]Terpyridine-6,6-dicarboxylic acid

C17H11N3O4 (321.0749526)

BenzeneMethanol, 3-amino-a-(bromomethyl)-4-(phenylmethoxy)-, (aR)-

C15H16BrNO2 (321.0364336)

Hydrazinecarbothioamide, 2-[(2-hydroxyphenyl)methylene]-N-1-naphthalenyl-

C18H15N3OS (321.09357800000004)

9H-fluoren-9-ylmethyl 2,5-dioxopyrrolidine-1-carboxylate

C19H15NO4 (321.10010300000005)

N-cyclopentyl-5-(2,4-dichlorophenyl)-2-methylpyrimidin-4-amine

C16H17Cl2N3 (321.07994620000005)

Naphtho[1,2-d]thiazolium,2-methyl-1-(3-sulfopropyl)-, inner salt

C15H15NO3S2 (321.049332)

TERT-BUTYL (4-BROMONAPHTHALEN-1-YL)CARBAMATE

C15H16BrNO2 (321.0364336)

4-[3,5-bis(trifluoromethyl)phenoxy]aniline

C14H9F6NO (321.0588296)

Methyl (2S)-(2-chlorophenyl)(4,7-dihydrothieno[2,3-c]pyridin-6(5H)-yl)acetate

C16H16ClNO2S (321.0590226)

4-(4-Aminophenylazo)phenylarsonic acid

C12H12AsN3O3 (321.00945820000004)

4-bromo-9-phenyl-9H-carbazole

C18H12BrN (321.0153052)

1-Cyclopropyl-7-ethoxy-6-fluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid

C16H16FNO5 (321.10124579999996)

1-([4-((2S)PYRROLIDIN-2-YL)PHENYL]SULFONYL)-4-CHLOROBENZENE

C16H16ClNO2S (321.0590226)

3-bromo-6-phenyl-9H-carbazole

C18H12BrN (321.0153052)

1-BroMo-N-phenylcarbazole

C18H12BrN (321.0153052)

5-Bromoindole-2-boronic acid, pinacol ester

C14H17BBrNO2 (321.05356320000004)

4-Bromo-1h-indole-2-boronic acid pinacol ester

C14H17BBrNO2 (321.05356320000004)

6-Bromoindole-2-boronic acid pinacol ester

C14H17BBrNO2 (321.05356320000004)

5-bromo-3-piperidin-4-yl-1H-indole-7-carboxamide

C14H16BrN3O (321.0476666)

7-chloro-3-(2-methylquinolin-6-yl)quinazolin-4-one

C18H12ClN3O (321.0668852)

3-(n-benzylsulfamoyl)-4-methoxyphenylboronic acid

C14H16BNO5S (321.08421960000004)

A-BROMO-1-[(1,1-DIMETHYLETHOXY)CARBONYL]-4-PIPERIDINEACETIC ACID

C12H20BrNO4 (321.0575620000001)

2-(N-Methylchloroacetyzamine)-5-chlorobenzophenone

C16H13Cl2NO2 (321.0323298)

Benzenesulfonamide,4-chloro-N-[3-(dimethylamino)propyl]-3-nitro-

C11H16ClN3O4S (321.0550006)

2-TERT-BUTOXYCARBONYLAMINO-5-TRIFLUOROMETHOXY-BENZOIC ACID

C13H14F3NO5 (321.082403)

4-Chloro-8-methyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9A-triaza-benzo[CD]azulene-1-thione

C16H20ClN3S (321.10663900000003)

D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors

[(8r,9r,10r,12r)-4-formyl-6,9-dihydroxy-14-oxa-1,11-diazatetracyclo[7.4.1.0²,⁷.0¹⁰,¹²]tetradeca-2,4,6-trien-8-yl]methoxycarboximidic acid

C14H15N3O6 (321.096081)

14,15-dimethoxy-10-methyl-16-oxo-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,8,10,12,14-octaen-10-ium-8-olate

C19H15NO4 (321.10010300000005)

4,5,9,10-tetrahydroxy-11-iminobenzo[b]fluorene-2-carbaldehyde

C18H11NO5 (321.0637196)

(2s)-2-amino-4-{[(1r)-1-[(2-carboxyethyl)-c-hydroxycarbonimidoyl]-2-sulfanylethyl]-c-hydroxycarbonimidoyl}butanoic acid

C11H19N3O6S (321.0994514)